Literature DB >> 9777617

Sexual behavior changes with vulvar vestibulitis syndrome.

G White1, M Jantos.   

Abstract

OBJECTIVE: To study the changes in normal sexual behavior that accompany the vulvar vestibulitis syndrome and to gauge an appropriate classification for the resulting sexual dysfunction. STUDY
DESIGN: Following full medical screening, questionnaires were administered to assess sexual history, illness behavior and vulvar discomfort. Forty patients who met the criteria of vestibulitis syndrome composed the study cohort.
RESULTS: The average duration of reported vulvar pain was 33 months (range, 3-240). The cohort showed no significant differences when compared with normative data on the sexual history form in their level of sexual desire, duration of intercourse or chance of female orgasm with intercourse or masturbation. Patients were: (1) highly likely to experience vulvar pain with intercourse (P < .001), (2) highly likely to have significantly reduced arousal potential (P < .001), (3) highly likely to complain of vulvar symptoms preventing intercourse from occurring (P < .001), (4) highly likely to have a reduced interest in intercourse and to have negative feelings toward it (P < .001); and (5) highly likely to refuse a partner's sexual advances (P < .001).
CONCLUSION: In the case of vulvar vestibulitis, the most appropriate Diagnostic and Statistical Manual of Mental Disorders, fourth edition, classification appears to be sexual dysfunction due to a general medical condition.

Entities:  

Mesh:

Year:  1998        PMID: 9777617

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

Review 1.  [Review of the literature on the psychoemotional reality of women with vulvodynia: difficulties met and strategies developed].

Authors:  M Cantin-Drouin; D Damant; D Turcotte
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

2.  Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study.

Authors:  P Nyirjesy; J D Sobel; M V Weitz; D J Leaman; M J Small; S P Gelone
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.